title: Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity?
abstract: The effective functioning of immunoglobulins and IgG mAbs in removing pathological cells requires that the antigen binding regions and the Fc (effector) domain act in concert. The hinge region that connects these domains itself presents motifs that engage Fc receptors on immune effector cells to achieve cell lysis. In addition, sequences in the lower hinge/CH2 and further down the CH2 region are involved in C1q binding and complement-mediated cell killing. Proteolytic enzymes of little relevance to human physiology were successfully used for decades to generate fragments of IgGs for reagent and therapeutic use. It was subsequently noted that tumor-related and microbial proteases also cleaved human IgG specifically in the hinge region. We have shown previously that the "nick" of just one of the lower hinge heavy chains of IgG unexpectedly prevented many effector functions without impacting antigen binding. Of interest, related single-cleaved IgG breakdown products were detected in breast carcinoma extracts. This suggested a pathway by which tumors might avoid host immune surveillance under a cloak of proteolytically-generated, dysfunctional antibodies that block competent IgG binding. The host immune system cannot be blind to this pathway since there exists a widespread, low-titer incidence of anti-hinge (cleavage-site) antibodies in the healthy population. The prevalence of anti-hinge reactivity may reflect an ongoing immune recognition of normal IgG catabolism. Tumor growth and bacterial infections potentially generate hostile proteolytic environments that may pose harsh challenges to host immunity. Recent findings involving physiologically-relevant proteases suggest that the potential loss of key effector functions of host IgGs may result from subtle and limited proteolytic cleavage of IgGs and that such events may facilitate the incursion of invasive cells in local proteolytic settings.
authors.affiliation: Biologics Research, Centocor R&D Inc., Radnor, PA, USA. rbrezski@its.jnj.com
authors.forename: Randall J
authors.initials: RJ
authors.lastname: Brezski
authors.forename: Robert E
authors.initials: RE
authors.lastname: Jordan
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000378:metabolism; D001323:Autoantibodies / Q000276:immunology; D001424:Bacterial Infections / Q000201:enzymology* / Q000276:immunology* / Q000628:therapy; D001426:Bacterial Proteins / Q000378:metabolism; D052058:Hinge Exons / Q000235:genetics / Q000276:immunology; D006801:Humans; D057131:Immune Evasion; D007074:Immunoglobulin G / Q000276:immunology / Q000378:metabolism*; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000201:enzymology* / Q000276:immunology* / Q000628:therapy; D010447:Peptide Hydrolases / Q000378:metabolism*; D019139:Tumor Escape
chemical_list: D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D001426:Bacterial Proteins; D007074:Immunoglobulin G; D010447:Peptide Hydrolases
references.citation: J Mol Biol. 2002 May 24;319(1):9-18
references.pmid: 12051932
references.citation: J Biol Chem. 1994 May 27;269(21):15287-93
references.pmid: 8195166
references.citation: J Exp Med. 1993 Apr 1;177(4):1165-73
references.pmid: 8459210
references.citation: Infect Immun. 2001 Nov;69(11):7187-9
references.pmid: 11598100
references.citation: Nat Rev Cancer. 2001 Nov;1(2):118-29
references.pmid: 11905803
references.citation: Adv Immunol. 2006;90:1-50
references.pmid: 16730260
references.citation: Proc Natl Acad Sci U S A. 1976 Sep;73(9):3278-82
references.pmid: 1067619
references.citation: J Virol. 2001 Dec;75(24):12161-8
references.pmid: 11711607
references.citation: Adv Exp Med Biol. 1995;371A:609-11
references.pmid: 8526000
references.citation: J Clin Oncol. 2007 Aug 20;25(24):3712-8
references.pmid: 17704420
references.citation: Immunology. 1974 Apr;26(4):725-33
references.pmid: 4212065
references.citation: Biochemistry. 1998 Jun 30;37(26):9266-73
references.pmid: 9649307
references.citation: Annu Rev Cell Dev Biol. 2001;17:463-516
references.pmid: 11687497
references.citation: Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17864-9
references.pmid: 19815504
references.citation: J Immunol. 2006 Sep 15;177(6):3913-9
references.pmid: 16951354
references.citation: Nature. 1958 Sep 6;182(4636):670-1
references.pmid: 13590068
references.citation: Proc Natl Acad Sci U S A. 1971 Jun;68(6):1372-5
references.pmid: 5288389
references.citation: J Immunol. 1976 Mar;116(3):724-30
references.pmid: 1254951
references.citation: Science. 1960 Dec 9;132(3441):1770-1
references.pmid: 13729245
references.citation: Microbes Infect. 2005 Mar;7(3):476-84
references.pmid: 15792635
references.citation: J Clin Oncol. 2009 Mar 1;27(7):1122-9
references.pmid: 19164213
references.citation: Biochemistry. 2004 Dec 14;43(49):15540-9
references.pmid: 15581366
references.citation: Eur J Cancer. 2006 Apr;42(6):728-34
references.pmid: 16524717
references.citation: J Biol Chem. 2009 Dec 18;284(51):35390-402
references.pmid: 19850927
references.citation: Mol Immunol. 1988 Nov;25(11):1175-81
references.pmid: 2975762
references.citation: Clin Cancer Res. 2007 Sep 1;13(17):5133-43
references.pmid: 17785568
references.citation: J Clin Oncol. 2003 Nov 1;21(21):3940-7
references.pmid: 12975461
references.citation: Nat Rev Immunol. 2007 Sep;7(9):715-25
references.pmid: 17703228
references.citation: Immunity. 2007 Feb;26(2):205-13
references.pmid: 17306569
references.citation: J Mol Biol. 1998 Feb 6;275(5):861-72
references.pmid: 9480774
references.citation: Nat Rev Immunol. 2008 Jan;8(1):34-47
references.pmid: 18064051
references.citation: Mol Immunol. 2002 May;38(14):1073-83
references.pmid: 11955599
references.citation: Blood. 2002 Feb 1;99(3):754-8
references.pmid: 11806974
references.citation: Infect Immun. 2005 Mar;73(3):1515-22
references.pmid: 15731049
references.citation: EMBO J. 2002 Apr 2;21(7):1607-15
references.pmid: 11927545
references.citation: J Exp Med. 1999 Mar 1;189(5):843-53
references.pmid: 10049948
references.citation: EMBO J. 2001 Jun 15;20(12):3046-55
references.pmid: 11406581
references.citation: J Clin Oncol. 2008 Apr 10;26(11):1789-96
references.pmid: 18347005
references.citation: Science. 2003 Sep 5;301(5638):1374-7
references.pmid: 12920303
references.citation: Science. 2007 Sep 14;317(5844):1554-7
references.pmid: 17872445
references.citation: Expert Opin Biol Ther. 2007 Sep;7(9):1401-13
references.pmid: 17727329
references.citation: J Rheumatol. 1995 Jun;22(6):1075-85
references.pmid: 7674233
references.citation: Mol Immunol. 1986 Mar;23(3):319-30
references.pmid: 3487030
references.citation: J Immunol. 2008 Sep 1;181(5):3183-92
references.pmid: 18713989
references.citation: Eur J Immunol. 1999 Sep;29(9):2819-25
references.pmid: 10508256
references.citation: Biochem Biophys Res Commun. 2006 Mar 17;341(3):797-803
references.pmid: 16442075
references.citation: Nature. 1970 Oct 10;228(5267):160-2
references.pmid: 4990048
references.citation: Vox Sang. 1994;66(1):37-45
references.pmid: 7908473
references.citation: J Immunol. 1973 Oct;111(4):1274-6
references.pmid: 4199558
references.citation: J Immunol. 2005 Jun 15;174(12):7792-9
references.pmid: 15944283
references.citation: MAbs. 2010 Jan-Feb;2(1):84-100
references.pmid: 20065640
references.citation: J Am Chem Soc. 2007 Jun 6;129(22):6976-7
references.pmid: 17500521
references.citation: J Immunol. 1991 Oct 15;147(8):2657-62
references.pmid: 1833457
references.citation: J Clin Invest. 1998 Aug 1;102(3):576-83
references.pmid: 9691094
references.citation: J Biol Chem. 2001 Mar 2;276(9):6591-604
references.pmid: 11096108
references.citation: J Biol Chem. 1996 Feb 16;271(7):3659-66
references.pmid: 8631977
references.citation: Eur J Immunol. 1995 Nov;25(11):3128-33
references.pmid: 7489753
references.citation: Cell Mol Biol (Noisy-le-grand). 2002 May;48(3):271-8
references.pmid: 12030431
references.citation: Infect Immun. 1988 Oct;56(10):2717-22
references.pmid: 3166451
references.citation: Biochim Biophys Acta. 2000 Mar 7;1477(1-2):35-50
references.pmid: 10708847
references.citation: Circulation. 2003 Jun 10;107(22):2829-36
references.pmid: 12771009
references.citation: Nat Rev Cancer. 2007 Oct;7(10):800-8
references.pmid: 17851543
references.citation: J Biol Chem. 1999 Jul 30;274(31):21491-4
references.pmid: 10419448
references.citation: Nature. 1991 Oct 24;353(6346):765-9
references.pmid: 1944535
references.citation: J Immunol. 1995 May 1;154(9):4404-13
references.pmid: 7722297
references.citation: Int J Pept Protein Res. 1996 Jul;48(1):48-55
references.pmid: 8844262
references.citation: Nature. 1988 Apr 21;332(6166):738-40
references.pmid: 3258649
references.citation: J Infect Dis. 1985 Apr;151(4):589-98
references.pmid: 3919115
references.citation: Thromb Haemost. 1999 Aug;82(2):846-9
references.pmid: 10605792
references.citation: J Exp Med. 1983 Apr 1;157(4):1184-96
references.pmid: 6220107
references.citation: Immunol Lett. 2002 Apr 1;81(1):41-8
references.pmid: 11841844
references.citation: Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11810-3
references.pmid: 8524854
references.citation: Nature. 2007 May 24;447(7143):482-6
references.pmid: 17495932
references.citation: Nature. 1988 Apr 7;332(6164):563-4
references.pmid: 2965792
references.citation: Blood. 1995 Jan 15;85(2):548-51
references.pmid: 7812010
references.citation: Proc Natl Acad Sci U S A. 1969 May;63(1):78-85
references.pmid: 5257969
references.citation: Mol Immunol. 1995 Nov;32(16):1271-81
references.pmid: 8559151
references.citation: Mol Immunol. 2008 Apr;45(7):1837-46
references.pmid: 18157932
references.citation: APMIS. 1996 May;104(5):321-38
references.pmid: 8703438
references.citation: Curr Opin Biotechnol. 2009 Dec;20(6):685-91
references.pmid: 19896358
references.citation: J Immunol. 2000 May 15;164(10):5313-8
references.pmid: 10799893
references.citation: Int J Cancer. 1975 Sep 15;16(3):456-64
references.pmid: 1176203
references.citation: Infect Immun. 1992 Dec;60(12):5057-64
references.pmid: 1333448
references.citation: J Clin Invest. 1985 Aug;76(2):723-30
references.pmid: 3928684
references.citation: Mol Immunol. 2008 May;45(10):2951-61
references.pmid: 18339427
references.citation: Infect Immun. 2003 Jan;71(1):211-7
references.pmid: 12496168
references.citation: J Exp Med. 1991 Jun 1;173(6):1483-91
references.pmid: 1827828
references.citation: Mol Immunol. 1990 Dec;27(12):1237-40
references.pmid: 2148808
references.citation: Mol Immunol. 1986 Dec;23(12):1365-72
references.pmid: 2434846
references.citation: Cancer Res. 2008 Aug 1;68(15):6368-76
references.pmid: 18676862